Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • C vs GSK✓SelectedUSD · GSKC vs GSK performance historyLatest closeAs of-1.14%11/17
Stock and ETF performance explorer

C vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+192.8%
GSK return
+104.0%
Excess return
+88.9%
Maximum drawdown
-56.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.1%-2.3%+1.2%-0.3%
7D-1.9%-3.0%+1.1%-0.9%
30D-2.9%+0.4%-3.3%-3.2%
3M-12.9%-1.2%-11.7%-12.9%
6M-1.8%+0.9%-2.7%-2.9%
YTD+4.9%+4.0%+0.9%+2.1%
1Y+24.7%+7.3%+17.4%+19.8%
3Y+187.7%+57.1%+130.6%+126.3%
5Y+112.4%+43.0%+69.5%+71.2%
10Y+192.8%+103.1%+89.8%+107.4%
All+192.8%+104.0%+88.9%+107.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling